Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:AIMDWNASDAQ:BBLGWOTCMKTS:CLLKFOTCMKTS:SMMNY On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAIMDWAinos$0.12-7.7%$0.13$0.03▼$0.37N/AN/A17,072 shs700 shsBBLGWBone Biologics$15.00+11.1%$14.69$3.00▼$95.04N/AN/A1,915 shs200 shsCLLKFBICO Group AB (publ)C$3.80+1.6%C$3.71C$2.59▼C$5.60N/AN/A1,568 shs1,800 shsSMMNYSiemens Healthineers$27.84+0.7%$26.77$23.28▼$30.19N/AN/A141,972 shs611,207 shsBeginner's Guide To Retirement StocksEnter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAIMDWAinos-13.33%-0.23%-19.00%+18.18%+88.68%BBLGWBone Biologics0.00%0.00%+11.11%-25.74%-65.52%CLLKFBICO Group AB (publ)+1.60%+8.70%+8.57%+24.59%-1.55%SMMNYSiemens Healthineers-0.36%+1.24%+4.70%+1.88%-4.23%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAIMDWAinosN/AN/AN/AN/AN/AN/AN/AN/ABBLGWBone BiologicsN/AN/AN/AN/AN/AN/AN/AN/ACLLKFBICO Group AB (publ)N/AN/AN/AN/AN/AN/AN/AN/ASMMNYSiemens HealthineersN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAIMDWAinos 0.00N/AN/AN/ABBLGWBone Biologics 0.00N/AN/AN/ACLLKFBICO Group AB (publ) 0.00N/AN/AN/ASMMNYSiemens Healthineers 3.50Strong BuyN/AN/ACurrent Analyst Ratings BreakdownLatest SMMNY, AIMDW, CLLKF, and BBLGW Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/16/2025SMMNYSiemens HealthineersDZ BankSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeHold ➝ Strong-Buy4/25/2025SMMNYSiemens HealthineersHSBCSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeBuy4/25/2025SMMNYSiemens HealthineersHsbc Global ResSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeHold ➝ Strong-Buy(Data available from 7/2/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAIMDWAinos$106.21KN/AN/AN/AN/AN/ABBLGWBone BiologicsN/AN/AN/AN/AN/AN/ACLLKFBICO Group AB (publ)N/AN/AN/AN/AN/AN/ASMMNYSiemens HealthineersN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAIMDWAinosN/AN/A0.00∞N/AN/AN/AN/AN/ABBLGWBone BiologicsN/AN/A0.00∞N/AN/AN/AN/AN/ACLLKFBICO Group AB (publ)N/AN/A0.00∞N/AN/AN/AN/AN/ASMMNYSiemens HealthineersN/AN/A0.00∞N/AN/AN/AN/A7/30/2025 (Estimated)Latest SMMNY, AIMDW, CLLKF, and BBLGW EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails7/30/2025N/ASMMNYSiemens Healthineers$0.3548N/AN/AN/A$6.45 billionN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAIMDWAinosN/AN/AN/AN/AN/ABBLGWBone BiologicsN/AN/AN/AN/AN/ACLLKFBICO Group AB (publ)N/AN/AN/AN/AN/ASMMNYSiemens Healthineers$0.291.04%N/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAIMDWAinosN/ABBLGWBone BiologicsN/ACLLKFBICO Group AB (publ)N/ASMMNYSiemens HealthineersN/AInsider OwnershipCompanyInsider OwnershipAIMDWAinosN/ABBLGWBone BiologicsN/ACLLKFBICO Group AB (publ)N/ASMMNYSiemens HealthineersN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAIMDWAinos40N/AN/ANot OptionableBBLGWBone Biologics2N/AN/ANot OptionableCLLKFBICO Group AB (publ)880N/AN/ANot OptionableSMMNYSiemens Healthineers71,000N/AN/ANot OptionableSMMNY, AIMDW, CLLKF, and BBLGW HeadlinesRecent News About These CompaniesSMMNY - Siemens Healthineers AG ADR Valuation - MorningstarJune 28, 2025 | morningstar.comMSiemens Healthineers AG (SMMNY) - Yahoo FinanceJune 27, 2025 | au.finance.yahoo.comEQS-CMS: Siemens Healthineers AG: Release of a capital market informationJune 11, 2025 | markets.businessinsider.comSiemens to relocate Varian imaging system manufacturing to USMay 15, 2025 | beckershospitalreview.comBSiemens Healthineers to move some Varian manufacturing to CaliforniaMay 14, 2025 | fiercebiotech.comFSiemens Healthineers AG (ETR:SHL) Second-Quarter Results: Here's What Analysts Are Forecasting For This YearMay 11, 2025 | finance.yahoo.comSiemens Healthineers Second Quarter 2025 Earnings: Revenues Beat Expectations, EPS LagsMay 10, 2025 | finance.yahoo.comSiemens Healthineers lowers earnings forecast on expected tariff hitMay 8, 2025 | medtechdive.comMSiemens Healthineers reports higher pay for some executives, lower pay for othersMay 8, 2025 | medicaldesignandoutsourcing.comMHealthineers: Reviewing Q2 And Updating My Targets (Rating Upgrade)May 8, 2025 | seekingalpha.comSiemens Healthineers AG (SMMNY) Q2 2025 Earnings Call Highlights: Strong Revenue Growth and ...May 8, 2025 | finance.yahoo.comSiemens Healthineers sees up to $340 million tariff hit in second half of 2025May 7, 2025 | msn.comStrong Imaging Performance and Strategic Management Drive Positive Outlook for Siemens Healthineers AGMay 7, 2025 | tipranks.comSiemens Healthineers Posts Profit, Revenue Rise; Adjusts Guidance on Tariff UncertaintyMay 7, 2025 | wsj.comSiemens Healthineers posts revenue beat, but lowers floor of profit outlookMay 7, 2025 | reuters.comCardiovascular Image Fusion Software Market Analysis Report, 2025-2035, Featuring Ziehm Imaging, TeraRecon, OsiriX, Materialise, Siemens Healthineers and MoreMay 5, 2025 | globenewswire.comMore Impact, Together: Varian and Siemens Healthineers Portfolios Highlight More Impact, Innovations and More Breakthroughs Throughout Cancer Care Journey at ESTRO 2025May 1, 2025 | businesswire.comEQS-CMS: Siemens Healthineers AG: Release of a capital market informationApril 28, 2025 | markets.businessinsider.comSiemens Healthineers and Tower Health partner to enhance medical equipmentApril 4, 2025 | medicaldevice-network.comMSiemens to acquire Dotmatics in $5.1 billion deal in Life Science portfolio pushApril 3, 2025 | msn.comMedia Sentiment Over TimeSMMNY, AIMDW, CLLKF, and BBLGW Company DescriptionsAinos NASDAQ:AIMDW$0.12 -0.01 (-7.69%) As of 01:44 PM EasternAinos, Inc., a healthcare company, engages in developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications. The company offers COVID-19 antigen rapid test kit and Ainos' cloud-based test management App, a cloud-based test management platform comprising an antigen rapid test kit, a personal application, and an enterprise app; COVID-19 nucleic acid test; volatile organic compounds point-of-care testing; Very Low-Dose Oral Interferon Alpha, a low-dose oral interferon alpha formulation based IFN-a's broad treatment applications; and Synthetic RNA developing a SRNA technology platform in Taiwan. It also provides women's health, pneumonia, Ainos Pen, AI Nose, and other products. Ainos, Inc. was formerly known as Amarillo Biosciences, Inc. and changed its name to Ainos, Inc. in May 2021. The company was incorporated in 1984 and is based in San Diego, California.Bone Biologics NASDAQ:BBLGW$15.00 +1.50 (+11.11%) As of 07/1/2025Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. The company's NELL-1/DBM, an osteopromotive recombinant protein that provides target specific control over bone regeneration. It also develops NELL-1/DBM Fusion Device for use in spinal fusion procedures in skeletally mature patients with spinal degenerative disc disease at one level from L2-S1. The company's platform technology is used in delivering enhanced outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. It has a license agreement with the UCLA Technology Development Group to develop and commercialize NELL-1 for spinal fusion applications. Bone Biologics Corporation was founded in 2004 and is headquartered in Burlington, Massachusetts.BICO Group AB (publ) OTCMKTS:CLLKFC$3.80 +0.06 (+1.60%) As of 07/1/2025 12:21 PM EasternBICO Group AB (publ) operates as a bioconvergence company in North America, Europe, Asia, and internationally. It operates through three segments: Bioprinting, Biosciences, and Bioautomation. The Bioprinting segment offers products, solutions, and services that enable proliferation of 3D cell culture and 3D printing. The Biosciences segment provides instruments that enable the handling of cells and rare samples, and rapid transfer of liquids and reagents, as well as downstream analysis platforms. The Bioautomation segment offers end-to-end products and services in precision dispensing, advanced sample preparation, multiplex analysis and assay miniaturization, diagnostic and medical device manufacturing for life science and diagnostic industries. It primarily serves medical, pharmaceutical, and cosmetic industries. The company offers its products through sales organizations, as well as through an extensive distributor network. The company was formerly known as Cellink AB (publ) and changed its name to BICO Group AB (publ) in August 2021. BICO Group AB (publ) was incorporated in 2016 and is headquartered in Gothenburg, Sweden.Siemens Healthineers OTCMKTS:SMMNY$27.84 +0.20 (+0.72%) As of 03:57 PM EasternSiemens Healthineers AG, through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers worldwide. It operates through four segments: Imaging, Diagnostics, Varian, and Advanced Therapies. The Imaging segment provides magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound systems. Its Diagnostics segment offers in-vitro diagnostic products and services to healthcare providers in laboratory and point-of-care diagnostics; and workflow solutions for laboratories and informatics products. The Varian segment provides cancer care technologies, solutions, and services to oncology departments in hospitals and clinics; and technology-enabled optimized workflows, clinical services, and digital solutions and applications for managing treatment and therapy. Its Advanced Therapies segment offers products that are designed to support image-guided minimally invasive treatments in various areas, such as cardiology, interventional radiology, and surgery; and angiography systems and mobile C-arms. It offers essential technical customer service, such as maintenance and repair; medical equipment performance management; training; clinical education and e-learning; planning and design; financing; asset management; and managed departmental services for laboratories and healthcare facilities, as well as digital healthhcare consulting, products, and services. The company is headquartered in Forchheim, Germany. Siemens Healthineers AG operates as a subsidiary of Siemens Aktiengesellschaft. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Insider Selling at NVIDIA Could Turn Into an Opportunity Whiplash for Investors: AeroVironment's Confusing Stock Signals Jefferies Raises Broadcom Price Target to $315: 19% Upside Ahead Dan Ives’ Bold $5 Trillion Forecast for Microsoft Stock 3 Utility Stocks That Combine Income and Stability 2 Reasons to Buy Trade Desk Stock Now and 1 Warning Sign Toast Stock: A Fast-Growing Mid-Cap Eyeing Further Upside Breakout Alert: Disney Stock Hits Multi-Year High Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
